Stockscreener 앱 받기
19.62
0.86%
-0.17
시간 외 거래:
19.62
전일 마감가:
$19.79
열려 있는:
$19.8
하루 거래량:
271.77K
Relative Volume:
0.56
시가총액:
$1.06B
수익:
$2.22M
순이익/손실:
$-40.51M
주가수익비율:
-15.27
EPS:
-1.2847
순현금흐름:
$-46.53M
1주 성능:
+5.31%
1개월 성능:
+10.22%
6개월 성능:
+206.56%
1년 성능:
+0.00%
1일 변동 폭
$19.46
$20.68
1주일 범위
$18.18
$20.68
52주 변동 폭
$5.14
$29.46
Upstream Bio Inc Stock (UPB) Company Profile
명칭
Upstream Bio Inc
전화
781-208-2466
주소
890 WINTER STREET, SUITE 200, WALTHAM
UPB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
UPB
Upstream Bio Inc
|
19.62 | 1.07B | 2.22M | -40.51M | -46.53M | -1.2847 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Upstream Bio Inc Stock (UPB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-11-05 | 개시 | JP Morgan | Overweight |
| 2024-11-05 | 개시 | Piper Sandler | Overweight |
| 2024-11-05 | 개시 | TD Cowen | Buy |
| 2024-11-05 | 개시 | William Blair | Outperform |
Upstream Bio Inc 주식(UPB)의 최신 뉴스
Upstream Bio's (UPB) Sell (D-) Rating Reaffirmed at Weiss Ratings - MarketBeat
Will Rising Interest Rates Hurt Vintage Coffee and Beverages Limiteds Profit MarginsMonthly Performance Summary & Free Stop-Loss Planning for Your Portfolio - earlytimes.in
Measuring Upstream Bio Inc.’s beta against major indicesJuly 2025 News Drivers & Risk Adjusted Buy/Sell Alerts - newser.com
What does recent volatility data suggest for Upstream Bio Inc.Weekly Profit Analysis & Stepwise Entry and Exit Trade Signals - newser.com
What drives Upstream Bio Inc stock priceVolume Weighted Average Price & Plan Your Future With Strategic Investing - earlytimes.in
Visualizing Upstream Bio Inc. stock with heatmapsJuly 2025 Rallies & Technical Analysis for Trade Confirmation - newser.com
Can volume confirm reversal in Upstream Bio Inc.Trade Entry Report & AI Forecasted Entry/Exit Points - newser.com
Applying Elliott Wave Theory to Upstream Bio Inc.July 2025 Setups & Daily Stock Trend Watchlist - newser.com
Upstream Bio (UPB): Assessing Valuation as Shares Climb 7% Over the Past Week - Yahoo
Assessing Upstream Bio (UPB) Valuation After New Verekitug Phase 2 Data and Investor Interest Surge - Sahm
Upstream Bio, Inc. (NASDAQ:UPB) Receives Consensus Recommendation of "Buy" from Brokerages - MarketBeat
Why Upstream Bio (UPB) Is Up 14.0% After Positive Phase 2 Verekitug Data and Novel Dosing Approach - Sahm
News impact scoring models applied to Upstream Bio Inc.2025 Top Decliners & Safe Capital Growth Trade Ideas - newser.com
Is Upstream Bio Inc. forming a reversal patternJuly 2025 Update & Community Supported Trade Ideas - newser.com
Is Upstream Bio Inc. stock attractive for passive investorsMarket Growth Summary & AI Driven Stock Price Forecasts - newser.com
Earnings visualization tools for Upstream Bio Inc.July 2025 Earnings & Trade Opportunity Analysis - newser.com
Why retail investors pile into Upstream Bio Inc. stock2025 Market Outlook & Intraday High Probability Setup Alerts - newser.com
Upstream Bio Inc Stock Analysis and ForecastPrice Channel Trading & Free Popular Stock Picks Selection - earlytimes.in
Is Upstream Bio Inc. building a consolidation baseTrade Analysis Summary & Scalable Portfolio Growth Ideas - newser.com
Upstream Bio (NASDAQ:UPB) Trading 4.2% HigherStill a Buy? - MarketBeat
Upstream Bio Presents Data Showing Structural and Mechanistic Drivers of Verekitug’s Potent Pharmacodynamic Activity and Differentiated Clinical Profile at European Respiratory Society Congress - The Manila Times
Upstream Bio Presents Data Showing Structural and - GlobeNewswire
24-Week TSLP Inhibition: Upstream Bio's Verekitug Shows Breakthrough Respiratory Disease Treatment Data - Stock Titan
Upstream Bio, Inc. $UPB Shares Sold by Goldman Sachs Group Inc. - Defense World
Upstream Bio Inc (UPB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Upstream Bio Inc 주식 (UPB) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | Director |
Oct 15 '24 |
Buy |
17.00 |
825,000 |
14,025,000 |
4,554,873 |
| AI Upstream LLC | 10% Owner |
Oct 15 '24 |
Buy |
17.00 |
1,175,000 |
19,975,000 |
1,175,000 |
5.74%
자본화:
|
볼륨(24시간):